{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:51:39Z","timestamp":1740142299593,"version":"3.37.3"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["17K 15946"],"award-info":[{"award-number":["17K 15946"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2020,6,24]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>We previously demonstrated that the reduced expression in immortalized\ncells (REIC)\/dikkopf-3 (Dkk-3) gene was downregulated in various malignant tumors, and that an adenovirus\nvector carrying the REIC\/Dkk-3 gene, termed Ad-REIC induced cancer-selective apoptosis\nin pancreatic cancer and hepatocellular carcinoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this study, we examined the therapeutic effects of Ad-REIC in biliary cancer using a second-\ngeneration Ad-REIC (Ad-SGE-REIC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Human biliary cancer cell lines (G-415, TFK-1) were used in this study. The cell viability\nand apoptotic effect of Ad-SGE-REIC were assessed in vitro using an MTT assay and Hoechst staining.\nThe anti-tumor effect in vivo was assessed in a mouse xenograft model. We also assessed the\ntherapeutic effects of Ad-SGE-REIC therapy with cisplatin. Cell signaling was assessed by Western\nblotting.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Ad-SGE-REIC reduced cell viability, and induced apoptosis in biliary cancer cell lines via\nthe activation of the c-Jun N-terminal kinase pathway. Ad-SGE-REIC also inhibited tumor growth in a\nmouse xenograft model. This effect was further enhanced in combination with cisplatin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>Ad-SGE-REIC induced apoptosis and inhibited tumor growth in biliary cancer cells.\nREIC\/Dkk-3 gene therapy using Ad-SGE-REIC is an attractive therapeutic tool for biliary cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566523220666200309125709","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T12:48:01Z","timestamp":1583758081000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Promising Gene Therapy Using an Adenovirus Vector Carrying REIC\/Dkk-3 Gene for the Treatment of Biliary Cancer"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-2882","authenticated-orcid":true,"given":"Emi","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-2707","authenticated-orcid":true,"given":"Daisuke","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-8123","authenticated-orcid":true,"given":"Hidenori","family":"Shiraha","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-292X","authenticated-orcid":true,"given":"Hironari","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-9671","authenticated-orcid":true,"given":"Atsushi","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-5754","authenticated-orcid":true,"given":"Masaya","family":"Iwamuro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-4748","authenticated-orcid":true,"given":"Masami","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Center for Innovative Clinical Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-6584","authenticated-orcid":true,"given":"Hiromi","family":"Kumon","sequence":"additional","affiliation":[{"name":"Innovation Center Okayama for Nanobio-Targeted Therapy, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-7146","authenticated-orcid":true,"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin 2019,69(1),7-34","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11894-017-0542-4","volume":"19","author":"Doherty B.","year":"2017","unstructured":"Doherty B.; Nambudiri V.E.; Palmer W.C.; Update on the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep 2017,19(1),2","journal-title":"Curr Gastroenterol Rep"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"Valle J.","year":"2010","unstructured":"Valle J.; Wasan H.; Palmer D.H.; Cunningham D.; Anthoney A.; Maraveyas A.; Madhusudan S.; Iveson T.; Hughes S.; Pereira S.P.; Roughton M.; Bridgewater J.; Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010,362(14),1273-1281","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","volume":"103","author":"Okusaka T.","year":"2010","unstructured":"Okusaka T.; Nakachi K.; Fukutomi A.; Mizuno N.; Ohkawa S.; Funakoshi A.; Nagino M.; Kondo S.; Nagaoka S.; Funai J.; Koshiji M.; Nambu Y.; Furuse J.; Miyazaki M.; Nimura Y.; Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 2010,103(4),469-474","journal-title":"Br J Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/bbrc.1999.2067","volume":"268","author":"Tsuji T.","year":"2000","unstructured":"Tsuji T.; Miyazaki M.; Sakaguchi M.; Inoue Y.; Namba M.; A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000,268(1),20-24","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-05-0829","volume":"65","author":"Abarzua F.","year":"2005","unstructured":"Abarzua F.; Sakaguchi M.; Takaishi M.; Nasu Y.; Kurose K.; Ebara S.; Miyazaki M.; Namba M.; Kumon H.; Huh N.H.; Adenovirus-mediated overexpression of REIC\/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 2005,65(21),9617-9622","journal-title":"Cancer Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/jgh.12501","volume":"29","author":"Uchida D.","year":"2014","unstructured":"Uchida D.; Shiraha H.; Kato H.; Nagahara T.; Iwamuro M.; Kataoka J.; Horiguchi S.; Watanabe M.; Takaki A.; Nouso K.; Nasu Y.; Yagi T.; Kumon H.; Yamamoto K.; Potential of adenovirus-mediated REIC\/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J Gastroenterol Hepatol 2014,29(5),973-983","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.cgt.7701071","volume":"14","author":"Edamura K.","year":"2007","unstructured":"Edamura K.; Nasu Y.; Takaishi M.; Kobayashi T.; Abarzua F.; Sakaguchi M.; Kashiwakura Y.; Ebara S.; Saika T.; Watanabe M.; Huh N.H.; Kumon H.; Adenovirus-mediated REIC\/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 2007,14(9),765-772","journal-title":"Cancer Gene Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cgt.2008.58","volume":"16","author":"Kawasaki K.","year":"2009","unstructured":"Kawasaki K.; Watanabe M.; Sakaguchi M.; Ogasawara Y.; Ochiai K.; Nasu Y.; Doihara H.; Kashiwakura Y.; Huh N.H.; Kumon H.; Date H.; REIC\/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7\/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 2009,16(1),65-72","journal-title":"Cancer Gene Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/apt.15050","volume":"49","author":"Gonzalez-Carmona M.A.","year":"2019","unstructured":"Gonzalez-Carmona M.A.; Bolch M.; Jansen C.; Vogt A.; Sampels M.; Mohr R.U.; van Beekum K.; Mahn R.; Praktiknjo M.; Nattermann J.; Trebicka J.; Branchi V.; Matthaei H.; Manekeller S.; Kalff J.C.; Strassburg C.P.; Weism\u00fcller T.J.; Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma. Aliment Pharmacol Ther 2019,49(4),437-447","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"Andr\u00e9 T.","year":"2004","unstructured":"Andr\u00e9 T.; Tournigand C.; Rosmorduc O.; Provent S.; Maindrault-Goebel F.; Avenin D.; Selle F.; Paye F.; Hannoun L.; Houry S.; Gayet B.; Lotz J.P.; de Gramont A.; Louvet C.; Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 2004,15(9),1339-1343","journal-title":"Ann Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jjco\/hyv213","volume":"46","author":"Morizane C","year":"2016","unstructured":"Morizane C; Okusaka T; Mizusawa J; Randomized phase III\n  study of gemcitabine plus S-1 combination therapy versus gemcitabine\n  plus cisplatin combination therapy in advanced biliary tract\n  cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-\n  BT).  J Clin Oncol 2016,46(4_suppl),205-5","journal-title":"J Clin Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"viii205","DOI":"10.1093\/annonc\/mdy282","volume":"29","author":"Sakai D","year":"2018","unstructured":"Sakai D; Kanai M; Kobayashi S; Randomized phase III study\n  of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin\n  (GC) for advanced biliary tract cancer (KHBO1401-\n  MITSUBA). Ann Oncol 2018,29(suppl_8),viii205-viii270","journal-title":"Ann Oncol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"Conroy T.","year":"2011","unstructured":"Conroy T.; Desseigne F.; Ychou M.; Bouch\u00e9 O.; Guimbaud R.; B\u00e9couarn Y.; Adenis A.; Raoul J.L.; Gourgou-Bourgade S.; de la Fouchardi\u00e8re C.; Bennouna J.; Bachet J.B.; Khemissa-Akouz F.; P\u00e9r\u00e9-Verg\u00e9 D.; Delbaldo C.; Assenat E.; Chauffert B.; Michel P.; Montoto-Grillot C.; Ducreux M.; FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011,364(19),1817-1825","journal-title":"N Engl J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"Von Hoff D.D.","year":"2013","unstructured":"Von Hoff D.D.; Ervin T.; Arena F.P.; Chiorean E.G.; Infante J.; Moore M.; Seay T.; Tjulandin S.A.; Ma W.W.; Saleh M.N.; Harris M.; Reni M.; Dowden S.; Laheru D.; Bahary N.; Ramanathan R.K.; Tabernero J.; Hidalgo M.; Goldstein D.; Van Cutsem E.; Wei X.; Iglesias J.; Renschler M.F.; Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013,369(18),1691-1703","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"Golan T.","year":"2019","unstructured":"Golan T.; Hammel P.; Reni M.; Van Cutsem E.; Macarulla T.; Hall M.J.; Park J.O.; Hochhauser D.; Arnold D.; Oh D.Y.; Reinacher-Schick A.; Tortora G.; Alg\u00fcl H.; O\u2019Reilly E.M.; McGuinness D.; Cui K.Y.; Schlienger K.; Locker G.Y.; Kindler H.L.; Maintenance olaparib for germline BRCA-Mutated metastatic pancreatic cancer. N Engl J Med 2019,381(4),317-327","journal-title":"N Engl J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"Rizvi S.","year":"2018","unstructured":"Rizvi S.; Khan S.A.; Hallemeier C.L.; Kelley R.K.; Gores G.J.; Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018,15(2),95-111","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S1470-2045(19)30733-8","volume":"21","author":"Tella S.H.","year":"2020","unstructured":"Tella S.H.; Kommalapati A.; Borad M.J.; Mahipal A.; Second-line therapies in advanced biliary tract cancers. Lancet Oncol 2020,21(1),e29-e41","journal-title":"Lancet Oncol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-015-0155-z","volume":"8","author":"Javle M.","year":"2015","unstructured":"Javle M.; Churi C.; Kang H.C.; Shroff R.; Janku F.; Surapaneni R.; Zuo M.; Barrera C.; Alshamsi H.; Krishnan S.; Mishra L.; Wolff R.A.; Kaseb A.O.; Thomas M.B.; Siegel A.B.; HER2\/neu-directed therapy for biliary tract cancer. J Hematol Oncol 2015,8(1),58","journal-title":"J Hematol Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/cco.2019.08.14","volume":"8","author":"Javle M.","year":"2019","unstructured":"Javle M.; Zhao H.; Abou-Alfa G.K.; Systemic therapy for gallbladder cancer. Linchuang Zhongliuxue Zazhi 2019,8(4),44","journal-title":"Linchuang Zhongliuxue Zazhi"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","volume":"36","author":"Javle M.","year":"2018","unstructured":"Javle M.; Lowery M.; Shroff R.T.; Weiss K.H.; Springfeld C.; Borad M.J.; Ramanathan R.K.; Goyal L.; Sadeghi S.; Macarulla T.; El-Khoueiry A.; Kelley R.K.; Borbath I.; Choo S.P.; Oh D.Y.; Philip P.A.; Chen L.T.; Reungwetwattana T.; Van Cutsem E.; Yeh K.H.; Ciombor K.; Finn R.S.; Patel A.; Sen S.; Porter D.; Isaacs R.; Zhu A.X.; Abou-Alfa G.K.; Bekaii-Saab T.; Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinoma. J Clin Oncol 2018,36(3),276-282","journal-title":"J Clin Oncol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.21037\/hbsn.2019.04.11","volume":"8","author":"Yang P.","year":"2019","unstructured":"Yang P.; Javle M.; Pang F.; Zhao W.; Abdel-Wahab R.; Chen X.; Meric-Bernstam F.; Chen H.; Borad M.J.; Liu Y.; Zou C.; Mu S.; Xing Y.; Wang K.; Peng C.; Che X.; Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients. Hepatobiliary Surg Nutr 2019,8(6),604-614","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1158\/0008-5472.CAN-08-0080","volume":"68","author":"Kashiwakura Y.","year":"2008","unstructured":"Kashiwakura Y.; Ochiai K.; Watanabe M.; Abarzua F.; Sakaguchi M.; Takaoka M.; Tanimoto R.; Nasu Y.; Huh N.H.; Kumon H.; Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC\/Dickkopf-3-induced apoptosis. Cancer Res 2008,68(20),8333-8341","journal-title":"Cancer Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/jgh.13757","volume":"32","author":"Sawahara H.","year":"2017","unstructured":"Sawahara H.; Shiraha H.; Uchida D.; Kato H.; Kato R.; Oyama A.; Nagahara T.; Iwamuro M.; Horiguchi S.; Tsutsumi K.; Mandai M.; Mimura T.; Wada N.; Takeuchi Y.; Kuwaki K.; Onishi H.; Nakamura S.; Watanabe M.; Sakaguchi M.; Takaki A.; Nouso K.; Yagi T.; Nasu Y.; Kumon H.; Okada H.; Promising therapeutic efficacy of a novel reduced expression in immortalized cells\/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma. J Gastroenterol Hepatol 2017,32(10),1769-1777","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087900","volume":"9","author":"Shien K.","year":"2014","unstructured":"Shien K.; Tanaka N.; Watanabe M.; Soh J.; Sakaguchi M.; Matsuo K.; Yamamoto H.; Furukawa M.; Asano H.; Tsukuda K.; Nasu Y.; Huh N.H.; Miyoshi S.; Kumon H.; Toyooka S.; Anti-cancer effects of REIC\/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2013.1777","volume":"7","author":"Watanabe M.","year":"2014","unstructured":"Watanabe M.; Nasu Y.; Kumon H.; Adenovirus-mediated REIC\/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review). Oncol Lett 2014,7(3),595-601","journal-title":"Oncol Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.gt.3301453","volume":"8","author":"Mizuguchi H.","year":"2001","unstructured":"Mizuguchi H.; Koizumi N.; Hosono T.; Utoguchi N.; Watanabe Y.; Kay M.A.; Hayakawa T.; A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 2001,8(9),730-735","journal-title":"Gene Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1089\/10430340050111368","volume":"11","author":"Croyle M.A.","year":"2000","unstructured":"Croyle M.A.; Yu Q.C.; Wilson J.M.; Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum Gene Ther 2000,11(12),1713-1722","journal-title":"Hum Gene Ther"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/cgt.2016.31","volume":"23","author":"Sawahara H.","year":"2016","unstructured":"Sawahara H.; Shiraha H.; Uchida D.; Kato H.; Nagahara T.; Iwamuro M.; Kataoka J.; Horiguchi S.; Watanabe M.; Sakaguchi M.; Takaki A.; Nouso K.; Nasu Y.; Kumon H.; Okada H.; Novel REIC\/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer. Cancer Gene Ther 2016,23(8),278-283","journal-title":"Cancer Gene Ther"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3892\/ijo_00000191","volume":"34","author":"Watanabe M.","year":"2009","unstructured":"Watanabe M.; Kashiwakura Y.; Huang P.; Ochiai K.; Futami J.; Li S.A.; Takaoka M.; Nasu Y.; Sakaguchi M.; Huh N.H.; Kumon H.; Immunological aspects of REIC\/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 2009,34(3),657-663","journal-title":"Int J Oncol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/jgh.13259","volume":"31","author":"Uchida D.","year":"2016","unstructured":"Uchida D.; Shiraha H.; Kato H.; Sawahara H.; Nagahara T.; Iwamuro M.; Kataoka J.; Horiguchi S.; Watanabe M.; Takaki A.; Nouso K.; Nasu Y.; Kumon H.; Yamamoto K.; Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells\/dickkopf-3 protein and peripheral blood mononuclear cells. J Gastroenterol Hepatol 2016,31(6),1154-1159","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"Le D.T.","year":"2015","unstructured":"Le D.T.; Uram J.N.; Wang H.; Bartlett B.R.; Kemberling H.; Eyring A.D.; Skora A.D.; Luber B.S.; Azad N.S.; Laheru D.; Biedrzycki B.; Donehower R.C.; Zaheer A.; Fisher G.A.; Crocenzi T.S.; Lee J.J.; Duffy S.M.; Goldberg R.M.; de la Chapelle A.; Koshiji M.; Bhaijee F.; Huebner T.; Hruban R.H.; Wood L.D.; Cuka N.; Pardoll D.M.; Papadopoulos N.; Kinzler K.W.; Zhou S.; Cornish T.C.; Taube J.M.; Anders R.A.; Eshleman J.R.; Vogelstein B.; Diaz L.A.; PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 2015,372(26),2509-2520","journal-title":"N Engl J Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2017.08.006","volume":"407","author":"Feng M.","year":"2017","unstructured":"Feng M.; Xiong G.; Cao Z.; Yang G.; Zheng S.; Song X.; You L.; Zheng L.; Zhang T.; Zhao Y.; PD-1\/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett 2017,407,57-65","journal-title":"Cancer Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40425-019-0692-z","volume":"7","author":"Liu X.","year":"2019","unstructured":"Liu X.; Yao J.; Song L.; Zhang S.; Huang T.; Li Y.; Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade. J Immunother Cancer 2019,7(1),204","journal-title":"J Immunother Cancer"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:59:17Z","timestamp":1599760757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180040\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523220666200309125709","relation":{},"ISSN":["1566-5232"],"issn-type":[{"type":"print","value":"1566-5232"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}